Catalyst Wire Dossier Catalyst Wire Dossier

ALXN1910

· Alexion Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALXN1910, covering 2025-02-27 to 2025-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1910 in Healthy Participants [Phase 1]

See pricing